ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 1 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,963,323 | -25.8% | 7,987,396 | 0.0% | 0.79% | -26.5% |
| Q3 2022 | $3,994,000 | +28.8% | 7,987,396 | +50.5% | 1.07% | -9.3% |
| Q2 2022 | $3,101,000 | -17.9% | 5,307,751 | 0.0% | 1.18% | -26.3% |
| Q1 2022 | $3,779,000 | -55.6% | 5,307,751 | -17.7% | 1.61% | -43.1% |
| Q4 2021 | $8,514,000 | -9.3% | 6,449,856 | +58.0% | 2.83% | +3.1% |
| Q3 2021 | $9,388,000 | -47.6% | 4,081,972 | 0.0% | 2.74% | -34.3% |
| Q2 2021 | $17,919,000 | -39.1% | 4,081,972 | +0.7% | 4.17% | -29.2% |
| Q1 2021 | $29,417,000 | +132.3% | 4,051,972 | +38.2% | 5.89% | +65.1% |
| Q4 2020 | $12,663,000 | +5.1% | 2,931,185 | 0.0% | 3.57% | -16.8% |
| Q3 2020 | $12,047,000 | -31.5% | 2,931,185 | 0.0% | 4.29% | -37.5% |
| Q2 2020 | $17,587,000 | -21.2% | 2,931,185 | -1.0% | 6.86% | -86.9% |
| Q1 2020 | $22,306,000 | -45.2% | 2,962,267 | +0.1% | 52.57% | +71.3% |
| Q4 2019 | $40,679,000 | +14.5% | 2,958,492 | -1.1% | 30.68% | -11.3% |
| Q3 2019 | $35,524,000 | – | 2,990,211 | – | 34.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
| RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
| Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
| Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
| Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
| Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |